Please use this identifier to cite or link to this item:
https://dora.health.qld.gov.au/qldresearchjspui/handle/1/2669
Title: | Does lung function change in the months after an asthma exacerbation in children? | Authors: | Vermeulen, F. Vael, R. Turner, S. Martin, J. Pijnenburg, M. W. Roberts, G. Pike, K. C. Petsky, H. Chang, Anne Szefler, S. J. Gergen, P. |
Issue Date: | 2021 | Source: | 32, (6), 2021, p. 1208-1216 | Pages: | 1208-1216 | Journal: | Pediatric Allergy and Immunology | Abstract: | Background: There are limited data describing lung function changes in children after an asthma exacerbation. Our hypothesis was that lung function does not fully recover in children in the months following an asthma exacerbation. Methods: We used a data set of children with asthma where lung function (including FEV1, FEV1/FVC ratio and FEF25-75) was measured at 3-month intervals over a year. Mixed-level models compared spirometry measured on two occasions 3 months apart before a single exacerbation (assessments 1 and 2) with measurements made on two occasions after the exacerbation (assessments 3 and 4), with adjustment for covariates. Changes in spirometry over a year were also analysed across those with exacerbations in no, one or more than one 3-month periods. Results: For the 113 children who had a single exacerbation, spirometry measured at assessments 1 or 2 did not differ from measurements at assessments 3 or 4 when the whole population was considered. When stratified into tertiles by change in %FEV1 between assessments 2 and 3, those with the greater reduction were more likely to be treated with long-acting beta-agonist, but in this category, %FEV1 at assessment 4 had returned to the value at assessment 1. %FEV1 did not change over a 12-month period within and between the three exacerbation categories (n = 809). Conclusion: One or more asthma exacerbation was not associated with a fall in lung function for the whole population. In a subset of individuals, lung function does fall after an exacerbation but returns to pre-exacerbation values after a period of months.L20109726052021-04-02 | DOI: | 10.1111/pai.13503 | Resources: | https://www.embase.com/search/results?subaction=viewrecord&id=L2010972605&from=exporthttp://dx.doi.org/10.1111/pai.13503 | | Keywords: | spirometry;multicenter study (topic);beta adrenergic receptor stimulating agentbudesonide;corticosteroid;leukotriene receptor blocking agent;long acting drug;adolescent;allergic asthma;article;asthma;child;controlled study;disease exacerbation;female;forced expiratory volume;forced vital capacity;fractional exhaled nitric oxide;human;lung function;major clinical study;male;mild persistent asthma;randomized controlled trial (topic);retrospective study;severe persistent asthma | Type: | Article |
Appears in Sites: | Children's Health Queensland Publications |
Show full item record
Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.